• Return to Headlines

Top 5 Companies in the Pharmaceuticals Industry With the Highest Debt to Equity Ratio (MDCO, ENDP, NEOS, CTLT, ZTS)

By Amy Schwartz

Below are the three companies in the Pharmaceuticals industry with the highest debt to equity ratios. The Debt/Equity ratio measures a company's leverage and a high level often implies that a company has financed much of its growth with debt.

Medicines Comp ranks highest with a a debt to equity ratio of 2,605.8. Endo Internation is next with a a debt to equity ratio of 1,707.0. Neos Therapeutic ranks third highest with a a debt to equity ratio of 758.4.

Catalent Inc follows with a a debt to equity ratio of 287.4, and Zoetis Inc rounds out the top five with a a debt to equity ratio of 279.8.

SmarTrend is tracking the current trend status for Medicines Comp and will alert subscribers who have MDCO in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest debt to equity ratio medicines comp :endp endo internation neos therapeutic catalent inc zoetis inc

Ticker(s): MDCO NEOS CTLT ZTS